Search clinical trials for: CL-108

Total 4839 results

Takeda

Active, not recruiting

A Study of TAK-102 in Adult With Previously-Treated Solid Tumors

Solid Tumors

Japan
Excision BioTherapeutics

Enrolling by invitation

Long-Term Follow-Up Study of HIV-1 Infected Adults Who Received EBT-101

HIV-1-infection

United States
Auris Medical AG

Completed

AM-101 in the Treatment of Post-Acute Tinnitus 2 (AMPACT2)

Tinnitus

Germany
Minoryx Therapeutics, S.L.

Active, not recruiting

A Clinical Study in Male Pediatric Patients With Cerebral X-linked Adrenoleukodystrophy (Cald) to Assess the Effects of MIN-102 Treatment on Disease Progression Prior to Human Stem Cell Transplant (HSCT) (NEXUS)

Cerebral Adrenoleukodystrophy

Spain, Germany, France, Argentina
OncoNano Medicine, Inc.

Completed

A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer

Breast Cancer | Colorectal Cancer | Ovarian Cancer | Prostate Cancer | Non-small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Urothelial Carcinoma

United States
Engrail Therapeutics INC

Withdrawn

ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures (ENACT)

Focal Epilepsy

United States
Veru Inc.

Terminated

To Determine an Effective Dose of VERU-100 for the Treatment of Advanced Prostate Cancer (VERU-100)

Advanced Prostate Adenocarcinoma

United States
Semnur Pharmaceuticals, Inc.
Worldwide Clinical Trials; Scilex Pharmaceuticals, Inc.

Completed

A Research Study to Characterize the Pharmacodynamics and Safety of Repeat Dose SP-102

Lumbosacral Radicular Pain

United States
Taiho Oncology, Inc.

Completed

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Renal Impairment

Advanced Solid Tumors

United States, Czechia, Serbia
Sensus Healthcare

Completed

A Retrospective Evaluation of Superficial Radiation Therapy (SRT) and Non-Melanoma Skin Cancer (NMSC)

Non-melanoma Skin Cancer

United States
Auris Medical, Inc.

Completed

AM-101 in the Treatment of Post-Acute Tinnitus 1 (AMPACT1)

Tinnitus

United States
Alexion Pharmaceuticals

Terminated

A Open Label Study in Previously Studied, SBC-103 Treatment Naïve MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously (CL01-T)

Mucopolysaccharidosis III, Type B (MPS IIIB) | Sanfilippo B

United Kingdom
Curis, Inc.

Completed

A Phase I Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of CUDC-101 in Patients With Advanced Solid Tumors

Tumors

United States
Taiho Pharmaceutical Co., Ltd.

Completed

A Phase I Study of TAS-102 in Solid Tumors

Advanced or Metastatic Solid Tumors

China
Ablynx

Completed

Study Evaluating Long-Term Safety Of ATN-103 In Subjects With Rheumatoid Arthritis

Rheumatoid Arthritis

United States, Russian Federation, Canada, Hungary, Japan, Serbia, South Africa, Switzerland
OcuCure Therapeutics, Inc.

Completed

Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X

Proliferative Diabetic Retinopathy (PDR)

Bangladesh
Adamis Pharmaceuticals Corporation

Unknown

Dose-Escalation and Safety Study of APC-100 for the Treatment of Prostate Cancer

Prostate Cancer

United States
Blaze Bioscience Australia Pty Ltd

Completed

Safety Study of a Fluorescent Marker to Visualize Cancer Cells

Skin Neoplasms

Australia
Aldagen

Terminated

ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases (UCBT-002)

Mucopolysaccharidosis | Inborn Errors of Metabolism | Lysosomal Storage Disorders | Inherited Metabolic Diseases | Peroxisomal Storage Diseases

United States
La Jolla Pharmaceutical Company

Completed

Study of the Safety of GCS-100 in Subjects With Chronic Lymphocytic Leukemia (PR-CS008)

Chronic Lymphocytic Leukemia

United States
Auris Medical AG

Completed

Efficacy of AM 101 in Patients With Acute Inner Ear Tinnitus

Tinnitus

Germany
Juventas Therapeutics, Inc.

Completed

Study to Evaluate the Safety of a Single Escalating Dose of ACRX-100 in Adults With Ischemic Heart Failure

Heart Failure

United States
Takeda

Terminated

Safety Study of TAK-128 in Subjects With Diabetic Peripheral Neuropathy

Diabetic Neuropathies
Showa Inan General Hospital
Tsumura USA

Completed

Efficacy and Safety of TJ-100 in the Treatment of Chronic Constipation

Chronic Constipation

Japan
Stromedix, Inc.

Withdrawn

Study of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA)

Chronic Allograft Dysfunction

United States
Boston Medical Center

Completed

Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia

Leukemia

United States
Zeria Pharmaceutical

Terminated

Safety and Tolerability of Z-100 in Patients With Early HIV Infection

HIV Infections

United States
Aerie Pharmaceuticals

Completed

Ocular Hypotensive Efficacy of AR-102

Glaucoma

United States
Otonomy, Inc.

Completed

OTO-104 for Meniere's Disease

Meniere's Disease

United States
Vertex Pharmaceuticals Incorporated

Recruiting

A Study to Evaluate the Relative Bioavailability and Food Effect of a VX-118 Tablet Formulation

Cystic Fibrosis

United States
Versameb AG
PPD

Not yet recruiting

A Phase 2a Study To Evaluate VMB-100 In Females With Stress Urinary Incontinence

Stress Urinary Incontinence
Tianjin ConjuStar Biologics Co., Ltd.

Recruiting

Study SC-101 in Subjects With Advanced Malignancies

Advanced Solid Tumor

China
Ankyra Therapeutics, Inc

Recruiting

Phase I Study of ANK-101 in Advanced Tumors (ANCHOR)

Solid Tumor | Advanced Solid Tumor | Metastatic Solid Tumor | Malignant Solid Tumor | Cutaneous Tumor | Subcutaneous Tumor | Metastasis to Soft Tissue

United States
Shijiazhuang Yiling Pharmaceutical Co. Ltd

Recruiting

A Study of Bio-008 in Subjects With Advanced or Metastatic Solid Tumours

Solid Tumor, Adult

China
Betta Pharmaceuticals Co., Ltd.

Recruiting

BPB-101 in Subjects With Metastatic or Locally Advanced Solid Tumors

Solid Tumor

China
Pyxis Oncology, Inc

Recruiting

Study of PYX-106 in Solid Tumors

Solid Tumor

United States, Spain, Belgium
Antengene Discovery Limited

Recruiting

A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies (ATRIUM)

Advanced Solid Tumors | Hematological Malignancies

Australia
Aardvark Therapeutics, Inc.
Children's Hospital Colorado; Stanford University

Recruiting

A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
The University of Hong Kong
Taiho Pharmaceutical Co., Ltd.

Recruiting

TAS-102 in Patients With Advanced, Refractory Pancreatic Adenocarcinoma

Pancreas Cancer

Hong Kong
Newave Pharmaceutical Inc

Recruiting

Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.

Acute Myeloid Leukemia | Multiple Myeloma | Myelofibrosis | Chronic Lymphocytic Leukemia | Non Hodgkin Lymphoma | Acute Lymphocytic Leukemia | Myelodysplastic/Myeloproliferative Neoplasm | Small Lymphocytic Lymphoma | Chronic Myelomonocytic Leukemia-2 | Richter Transformation | T-cell-prolymphocytic Leukemia and other conditions

United States
AnHeart Therapeutics Inc.

Recruiting

Basket Study of AB-106 for the Treatment of Patients With Solid Tumors With NTRK Fusion Gene

Solid Tumor

China
CorrectSequence Therapeutics Co., Ltd
First Affiliated Hospital of Guangxi Medical University

Active, not recruiting

A Clinical Study Evaluating the Safety and Efficacy of CS-101 in Treating Subjects With β-thalassemia

Beta-Thalassemia

China
Ultragenyx Pharmaceutical Inc

Active, not recruiting

A Study of the Safety and Tolerability of GTX-102 in Children With Angelman Syndrome

Angelman Syndrome

United States, United Kingdom, Canada, Australia, France, Germany, Spain, Israel
Peptomyc S.L.

Terminated

Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours (MYCure)

Pancreatic Cancer | Advanced Solid Tumors | CRC

Spain
Aviceda Therapeutics, Inc.

Terminated

A Phase 2 Study of Intravitreal AVD-104 in Diabetic Macular Edema

Diabetic Retinopathy | Diabetic Macular Edema

United States
Blue Blood Biotech Corp.

Completed

BB-101 for Treatment of Diabetic Lower Leg and Foot Ulcers

Diabetic Foot Ulcer

Taiwan
Paean Biotechnology Inc.

Completed

Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis

Dermatomyositis | Polymyositis

Korea, Republic of
Fondazione Telethon
Ospedale San Raffaele

Active, not recruiting

A Clinical Study to Evaluate the Use of a Cryopreserved Formulation of OTL-103 in Subjects With Wiskott-Aldrich Syndrome

Wiskott-Aldrich Syndrome

Italy, United States
Cellestia Biotech AG

Terminated

Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies

Breast Cancer | Adenoid Cystic Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | Osteosarcoma | Non-hodgkin Lymphoma | Glomus Tumor, Malignant | T-ALL

United States, Spain, Korea, Republic of, Germany, France, Switzerland
AstraZeneca

Completed

Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124

Hypertension

United States

Search clinical trials for: CL-108

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations